Biogenesis |
β2 |
Mouse; heart |
Formoterol (100 µg/kg, 24 or 48 h) |
↑ mtDNA ↑ PGC1α |
69 |
β |
Mouse; adult rat cardiomyocytes |
Isoproterenol (100 nM, 12–48 h) |
No effect |
70 |
β |
Mouse; heart |
Isoproterenol (15 mg/kg, 14 d) |
No effect |
70 |
β2 |
Mouse; left ventricle |
Formoterol (0.3 mg/kg, 24 h) |
No effect |
71 |
α1 |
Mouse; C2C12, HL-1 |
Midodrine (1–30 µM, 24 h) |
↑ PGC1α expression |
72 |
α1 |
Rat; heart |
Midodrine (0.3 mg/kg/d, 4 w) |
↑ PGC1α |
72 |
α1A |
Mice; heart |
Dabuzalgron (20 µg/kg/d, 7 d) |
↑ PGC1α expression |
73 |
Dynamics |
β |
Rat; H9c2 |
Isoproterenol (10 µM, 30 min) |
‒ fission ↑ Drp1 activation |
84 |
|
β |
Rat; H9c2 |
Isoproterenol (1 µM, 24 h) |
↑ fission |
70 |
β |
Mouse; HL-1 |
Isoproterenol (10 µM, 1 h) |
↑ fission ↑ Drp1 translocation |
85 |
|
β1* |
Mouse; HL-1 |
Isoproterenol (10 µM, 1 h) + CGP20712A (300 nM) |
↓ fission |
85 |
β2* |
Mouse; HL-1 |
Isoproterenol (10 µM, 1 h) + ICI 118,551 (300 nM) |
↑ fission |
85 |
β2* |
Mouse; heart |
β2 genetic deletion |
↑ fission ↑ Drp1 translocation |
85 |
All |
Rat; neonatal ventricular myocyte |
Norepinephrine (10 µM, 2–48 h) |
↑ fission |
93 |
α1* |
Rat; neonatal ventricular myocyte |
Norepinephrine (10 µM, 48 h) + Prazosin (1 µM) |
↓ fission |
93 |
α1 |
Rat; H9c2 |
Phenylephrine (10 µM, 30 min) |
↑ fission ↑ Drp1 activation |
84 |
Mitochondrial Calcium |
β |
Mouse; adult left ventricular myocytes |
Isoproterenol (500 nM, 5–20 min) |
↑ mitochondrial calcium |
86 |
β |
Rat; adult ventricular myocytes |
Isoproterenol (100 nM, 10 min) |
↑ mitochondrial calcium |
126 |
β |
Mouse; adult ventricular myocytes |
Isoproterenol (500 nM, 15 min) |
↑ mitochondrial calcium |
127 |
β1 |
Mouse; adult cardiomyocytes |
Dobutamine (32 ng/g/min, 30 min) |
↑ mitochondrial calcium |
131 |
α1 |
Rat; heart |
Methoxamine (10 µM, 2 min) |
↑ mitochondrial calcium |
134 |
α1 |
Rat; H9c2 |
Phenylephrine (100 µM, 120 s) |
↑ mitochondrial calcium |
137 |
α1 |
Rat; adult left ventricular myocytes |
Phenylephrine (10 µM, 30 min) |
↓ mitochondrial calcium |
145 |
α1B* |
Rat; adult left ventricular myocytes |
Phenylephrine (10 µM, 30 min) + CEC (1 mM) |
↑ mitochondrial calcium |
145 |
α1A* |
Rat; adult left ventricular myocytes |
Phenylephrine (10 µM, 30 min) + 5-MU (10 µM) |
↑ mitochondrial calcium |
145 |
OXPHOS |
All* |
Mouse; embryos |
AR genetic deletion |
↓ ATP content ↓ ECA ↓ OCR |
83 |
|
β |
Mouse; embryos |
AR genetic deletion + Isoproterenol (maternal, 0.2 mg/mL, 2–3 w) |
↑ ATP content ↑ ECA ↑ OCR |
83 |
|
α1 |
Mouse; embryos |
AR genetic deletion + Phenylephrine (maternal, 0.2 mg/mL, 3 w) |
↑ ATP content ↑ ECA ↑ OCR |
83 |
|
All |
Rat; adult cardiomyocytes |
Norepinephrine (1 µM, 5–120 min) |
↑ superoxide production |
154 |
|
β |
Mouse; HL-1 |
Isoproterenol (10 µM, 1 h) |
↑ basal OCR ↑ maximal OCR ↑ ATP-linked OCR ↑ ATP production |
85 |
|
β1* |
Mouse; HL-1 |
Isoproterenol (10 µM, 1 h) + GCP20712A (300 nM) |
↓ basal OCR ↓ maximal OCR ↓ ATP-linked OCR ↓ ATP production |
85 |
|
β |
Rat; H9c2 |
Isoproterenol (10 µM, 48 h) |
↑ complex I activity |
155 |
|
β |
Rabbit; cardiomyocytes |
Isoproterenol (0.1 µM, 15 min) |
↓ redox potential ↓ superoxide production |
160 |
|
β |
Mouse; left ventricular myocytes |
Isoproterenol (500 nM, 5–20 min) |
↓ membrane potential ‒ superoxide production ‒ ATP production |
127 |
|
β |
Mouse; neonatal mouse cardiomyocytes |
Isoproterenol (10 µM, 5–120 min) |
↑ superoxide production ‒ NAD+/NADH ratio |
135 |
|
β |
Rat; adult cardiomyocytes |
Isoproterenol (10 µM) |
↑ complex V activity |
162 |
|
β2* |
Mice; heart |
β2 genetic deletion |
↓ complex I activity ↓ complex II activity |
65 |
|
β2 |
Mouse; left ventricle |
Formoterol (0.3 mg/kg, 24 h) |
↑ complex I abundance |
71 |
|
β2 |
Mouse; heart |
β2 overexpression (200-fold) |
↓ ATP production |
8 |
|
β2* |
Mouse; HL-1 |
ICI 118, 551 (300 nM) |
↑ basal OCR ↑ maximal OCR ↑ ATP-linked OCR |
85 |
|
β2* |
Mouse; cardiomyocytes |
β2 genetic deletion |
‒ OCR |
85 |
|
β2 |
Mouse; heart |
Clenbuterol (1 mg/kg, 12 h) |
↑ complex V activity ↑ ATP production |
163 |
|
α1 |
Rat; H9c2 |
Phenylephrine (100 µM, 1 h) |
↑ basal OCR ↑ maximal OCR ↑ ATP-linked OCR ↑ reserve capacity ↑ superoxide production |
84 |
|
α1 |
Mouse; C2C12 |
Midodrine (30 µM, 24 h) |
↑ OCR ↑ ATP content ↑ complex II activity ↑ complex IV density |
72 |
|
α1 |
Rat; H9c2 |
Midodrine (30 µM, 24 h) |
↑ OCR ↑ ATP production |
72 |
|
α1A |
Mouse; heart |
Dabuzalgron (20 µg/kg/d, 7 d) |
↑ ATP content ↑ complex I expression ↑ complex III expression ↑ complex V expression |
73 |
|
α1A |
Rat; neonatal ventricular myocyte |
Dabuzalgron (10 µM, 24 h) |
↑ membrane potential |
73 |